Today’s articles on Sectors

Jessica Alba Sells Out By Chris DeMuth Jr. • 18 comments Is Gilead The Next Valeant? By Jonathan Weber • 71 comments Citigroup Inc. 2016 Q2 - Results - Earnings Call Slides By SA Transcripts • 1 comments Editors' Picks JAMA's HIV/AIDS Issue; New Treatment Recommendations: Importance To Gilead By DoctoRx Pokémon Go - Will This Google Cloud Burst Spawn REIT Windfalls? By Bill Stoller Are Realty Income Shorts Off Their Rocker? By Adam Aloisi Is Fitbit The Next Flip Camera? Maybe, But Current Valuation Is Attractive Given Upside Potential By Paul Goncalves, CFA The Bull Thesis For Farmland By Jussi Askola More Editors' Picks» Basic Materials Kinder Morgan's SNG Transaction: No Value, No Dividend Hike by The Traveling Investor Alcoa Inc.: Special Situation Of Released Value After Arconic Spin-Off by William Stamm 5 Gold Exploration Stocks To Put On Your Radar Now by Hard Asset Investments Barrick Gold: More Reasons Why It Will Soar by Fundamental Investing ConocoPhillips Stock Weakness A Buying Opportunity by Sarfaraz A. Khan More Basic Materials» Consumer Goods Bad News For Tesla: Batteries Only Live Once by Max Greve Is Under Armour The Next FANG Stock? by Shilpa Khire Tesla Autopilot Events Spinning Out Of Control by Kevin Wenck, CFA Tesla: It's A Story Stock, But What's The Story? by Aswath Damodaran Mondelez: Hersheys Acquisition Is Likely To Fail. So, What Is Next? by Willow Street Investments More Consumer Goods» Financial Wells Fargo & Co. 2016 Q2 - Results - Earnings Call Slides by SA Transcripts Bank Of America's Q2 2016 Earnings Results: The Numbers That Really Matter by WG Investment Research Got REIT Bonds? by Brad Thomas Buy Wells Fargo After Its Supposedly 'Disappointing' Earnings by Bob Ciura U.S. Bancorp 2016 Q2 - Results - Earnings Call Slides by SA Transcripts More Financial» Healthcare Gilead Sciences: Value Play Or Value Trap? by Kumquat Research Ackman Emerges Victorious Over Herbalife by Bram de Haas Carl Icahn Has A Pharma Crush by Activist Stocks MannKind - Afrezza Scripts Starting Off Modestly On Relaunch by Spencer Osborne Valeant Pharmaceuticals: Priced For Disaster by Achilles Research More Healthcare» Industrial Goods Victoria Gold Corp: Yukon Fever Will Fade, As Will The Share Price by Sean McEniry Here Are The Companies That Would Profit From The Trump Wall by SA News Team HD Supply: 23% Upside by Fundamental Investment Chart Industries No Longer Left For Dead by Stephen Simpson, CFA Atlas Copco AB ADR 2016 Q2 - Results - Earnings Call Slides by SA Transcripts More Industrial Goods» Services Capital Product Partners Update: The HMM Deal Is Done With CPLP Coming Out As One Clear Winner by Darren McCammon Chipotle: This Cold, Wet Burrito Is Stuffed With Opportunity by Bret Kenwell Union Pacific: All Aboard The Profit Train by Canuck Investments Starbucks: Moving Up The Scale by WestEnd511 The Benefits Shake Shack Could Offer McDonald's by Quinn Foley More Services» Technology How AT&T Became Relevant Again by Dana Blankenhorn What People Haven't Realized Yet About BlackBerry by Egon Zee Research Amazon's Clever Streaming Strategy: Downloads by Max Greve Verizon: A High-Yield Buffett Pick - Answer The Call by Simply Safe Dividends Apple's Lengthening iPhone Cycle Headwind by Stephen Rosenman More Technology» Utilities National Grid Looking For Financial Flexibility by Valuentum More Utilities» Please do not forward this email. It allows direct access to your Seeking Alpha Portfolio. Why are you receiving this? You subscribed to Sectors at Seeking Alpha. Unsubscribe from this email or manage all your Seeking Alpha email choices here. To ensure you receive these emails in the future, please add account@seekingalpha.com to your address book, contacts or list of safe senders. Sent by Seeking Alpha, 52 Vanderbilt Avenue, 13th floor, New York, NY 10017